• Rewiring Drug Research and Development through Human Data-Driven Discovery (HD3)

  2023-07-10

• Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms

  2023-01-01

• Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports

  2022-02-20

• Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors

  2022-01-01

• The COVID-19 explorer – An integrated, whole patient knowledge model of COVID-19 disease

  2022-01-01

• Target adverse event profiles for predictive safety in the postmarket setting

  2021-05-01

• A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development

  2010-01-01